Launch Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced a strategic development financing agreement with Gilead Sciences. The financing agreement will provide up to $210 million in funding to support select clinical studies of ...

BioPharma

The ophthalmic drugs market is experiencing optimistic market growth as a result of an increase in the global burden of the geriatric population, increasing cases of various eye disorders and

The ophthalmic drugs market is experiencing optimistic market growth as a result of an increase in the global burden of the geriatric population, increasing...

30.08.2022 - Secured up to US$170m in non-dilutive financing Received commitments for well supported US$90m equity financing; closed first tranche for US$41.9 million Expanded management team and US operations with appointment of C-Suite Executives Elected ... Seite 1